Services on Demand
- Cited by SciELO
- Access statistics
- Similars in SciELO
Print version ISSN 0101-2800
J. Bras. Nefrol. vol.33 no.1 São Paulo Jan./Mar. 2011
Luis Alberto Batista PeresI; Sarah Sella LangerI; Raysa Cristina SchmidtI; Roberto Arthur Bavaresco NackeI; Paulo Victor Muller FrancesconI; Rogério Cavalcante de AlmeidaI; Renan Macedo CoimbraI; Tailla Michelle RibasI; Tiago Dahrug BarrosI; Tiemi MatsuoII
IUniversidade Estadual do Oeste do Paraná - UNIOESTE
IIUniversidade Estadual de Londrina
Metabolic disorders are frequently observed in pediatric patients with renal lithiasis.
OBJECTIVES: Study the metabolic and anatomical alterations and perform the chemical analysis of stones found in children with nephrolithiasis in our region.
METHODS: A retrospective study on 158 children with evidence of recent renal stone formation was performed. One hundred and nine children concluded the metabolic study. Laboratory investigation consisted in two samples of 24-hour urine for calcium, uric acid, citrate, oxalate, sodium and creatinine; qualitative cystinuria, urinary pH following 12-hour fasting and water restriction, urine culture and chemical analysis when the stones were available. Renal imaging techniques included, at least, renal ultrasound and excretory urogram.
RESULTS: A cause for nephrolithiasis was identified in 96.3% of children. The main metabolic alteration was hypercalciuria (73.4%). Chemical analysis of stones showed calcium oxalate in 90.9% of the cases. Anatomical alterations were found in 18.0% of the investigated cases and the most frequently found alteration was pyelo-ureteral duplication (28.6%).
CONCLUSIONS: Hypercalciuria was the most frequently found disorder and pyelo-ureteral duplication was the most common anatomical alteration; moreover, calcium oxalate was the most frequent chemical constituent. The present study showed the characteristics of pediatric patients with nephrolithiasis in our region.
Keywords: nephrolithiasis, child, metabolic diseases.
Nephrolithiasis in pediatric patients is relatively rare. In different series of patients at all age ranges with renal lithiasis, the prevalence in children varies from 2 to 2.7%.1,2 Recent studies have shown that the annual incidence is increasing in different populations. 3,4 At the diagnosis, most calculi in children were found in the kidneys, with remnants being found in ureters.5 Several factors can predispose children to develop nephrolithiasis and among them, metabolic and genitourinary abnormalities are particularly important; these are often associated with diet, environmental factors and infectious causes. Nephrolithiasis is associated with considerable morbidity and has high recurrence rates.6
The knowledge on nephrolithiasis in children has increased in recent years. Most children with urinary lithiasis have underlying metabolic abnormalities, with hypercalciuria being the most prevalent.7,8,9 Other metabolic risk factors vary in frequency according to the different series.10,11 Some other metabolic alterations that have been described are hypocitraturia, hyperuricosuria, hyperoxaluria, renal tubular acidosis and cystinuria.12
Our study was the first to analyze metabolic risk factors in children with urinary calculi in our region. In this retrospective study, we evaluated the metabolic risk factors, clinical presentation, family history, anatomic alterations and chemical analysis of the calculi in children with nephrolithiasis that were referred to our institution for metabolic assessment. The objectives were to evaluate the presence of the main metabolic disorders, anatomic alterations and perform the chemical analysis of the calculi found in children with a recent diagnosis of nephrolithiasis in the west region of the state of Paraná.
A retrospective study was carried out in 158 children treated at the Service of Nephrology of the General Outpatient Clinic of Hospital Universitário do Oeste do Paraná, who presented evidence of recent nephrolithiasis, from 1995 to 2010. The inclusion criteria for this retrospective study included spontaneous, endoscopic or surgical elimination of calculi and/or radiological confirmation of their presence in the urinary tract in the previous six months. The 24-hour urinary data of patients with more than one sample were recorded, as well as family history, clinical presentation, chemical analysis of calculi and imaging assessment.
The laboratory investigation included two or more 24-hour urine samples, including calcium, uric acid, citrate, sodium, creatinine and calcium oxalate measurements, and uric acid, creatinine and parathormone in blood. Qualitative cystinuria, urinary pH after 12-hour fasting and water restriction, urine culture and chemical analysis of calculi were performed.
The laboratory methods employed and the reference values used for 24-hour urine samples were: calcium - atomic absorption spectrophotometry (< 4.0 mg/kg); uric acid - uricase enzymatic method (< 15 mg per kg); citrate - citrate-lyase enzymatic method (> 320 mg); sodium - selective ion method (< 150 mEq); creatinine - alkaline picrate method (> 1.000 mg) and urinary volume - volumetric measurement in Becker by visual analysis. For plasma measurements, the methods used were: calcium - colorimetric method (8,5-10,5 mg/dL); uric acid - uricase colorimetric method (2.0 to 7.0 mg/dL); creatinine - alkaline picrate method (0.7 to 1.4 mg/dL) and parathormone - intact molecule assay. For isolated urine sample analyses, the methods employed were: qualitative cystinuria - sodium nitroprusside test and urinary pH - measured by using reagent test strips with a methyl red and bromothymol blue indicator system. A decreased urinary volume was considered when at least one of the samples had a 24-hour urinary volume < 15 mL/kg. The chemical analysis was carried out using the colorimetric method.
The patients were divided in two groups according to age, with a cutoff of ten years, with 49 patients being younger and 60 older than ten years.
The Chi-square test and Fisher's Exact test were used to compare the variables. A p value < 0.05 was considered statistically significant. This study was approved by the Human Subject Research Ethics Committee of UNIOESTE.
The most frequent clinical presentations were renal colic (65.2%) and hematuria (24.8%). In patients younger than 10 years, the most common clinical presentation was hematuria and in the group aged above 10 years, renal colic was the most common presentation (p < 0.05). These data are shown in Table 1. A family history of nephrolithiasis was reported by 80% of the studied group.
Of the 158 patients, 109 concluded the metabolic study. At least one alteration was found in 96.3% of them. Patient mean age was 11.4 ± 4.7 years (ranging from 4 months to 18 years) and 54.1% were males. The main metabolic alterations identified in the study group were: hypercalciuria (73.4%), hypocitraturia (32.1%) and uric acid hyperexcretion (21.1%). The differences found between the age and sex distributions were not statistically significant (Tables 2 and 3, p > 0.05). There was a significant difference regarding the number of patients with low urinary volume and of those that were not investigated, being higher in the group older than 10 years (Table 3).
The chemical analysis of the calculi showed the presence of calcium oxalate in 90.9%, calcium carbonate in 54.5%, uric acid in 18.2%, phosphorus and magnesium in 9.1% of the cases.
Anatomic alterations were observed in 18.1% of the cases, with pyeloureteral duplication being found in four patients (28.6%), renal cyst in three (21.4%), neurogenic bladder in two (14.3%) and pyelocaliceal obstruction, extrarenal pelvis, horseshoe kidney, polycystic kidney disease and distal ureteral stenosis in one patient each.
The present study presents the main metabolic risk factors, the clinical presentation, the anatomic alterations and the family history of pediatric patients with nephrolithiasis that were referred to our institution for metabolic assessment.
Nephrolithiasis can occur at any age. The literature has shown that the mean age at diagnosis ranges from 7 to 10.3,13 In the present study, the mean age of patients was 11 years, with 40% of them being younger than 10 years at admission.
Metabolic abnormalities were found in 96.3% of the studied patients, with hypercalciuria, hypocitraturia and hyperuricosuria being the most important urinary metabolic risk factors. These data are similar to those from other studies.11,14 The distribution regarding sex among the pediatric patients that completed the metabolic assessment is similar. When the metabolic alterations were compared between the age groups < 10 and > 10 years, there were no statistically significant differences. The epidemiology of nephrolithiasis in the pediatric population is not as well defined as in the adult population. In the first decade of life, nephrolithiasis was more prevalent in the male sex, being the opposite in the second decade of life, as it was more prevalent in the female sex.15
Hypercalciuria is associated with the development of nephrolithiasis. In children with hypercalciuria, the prevalence of familial nephrolithiasis is 46 to 49%.11,16 Idiopathic hypercalciuria has been identified as the most frequent metabolic risk factor, detected in 40% to 69% of the cases.17,19 A positive family history seems to be the most important isolated risk factor.20 A large number of genes have been suggested as responsible for the pathogenesis of hipercalciúria.21-26 In the present study, 89.6% of the patients with hypercalciuria had a positive family history.
Other main metabolic disorders identified in the study group were hypocitraturia (32.1%) and hyperuricosuria (21.1%). Until recently, hypocitraturia was considered uncommon.10 Tefekli et al27 identified hypocitraturia as the most prevalent metabolic risk factor in children with nephrolithiasis (60.6%). Van Dervoort et al.4 also observed that hypocitraturia was the most commonly identified metabolic abnormality, present in 52% of the children studied between 2003-2005. Hyperuricosuria has been detected in 16 to 54% of the children.28-30
The signs and symptoms of pediatric nephrolithiasis are abdominal or flank pain, with or without hematuria, urinary tract infection and isolated hematuria.29,31 The classic renal colic is rarer in children, who usually have more vague symptoms, such as flank pain or even painless hematuria.32 The most common clinical presentation in patients aged below 10 and above 10 years was hematuria and renal colic, respectively. These data are in agreement with the study by Alpav et al.31 Calcium oxalate is the main component of the analyzed calculi.28 In the present study, we found calcium oxalate in 90.9% of the analyzed calculi. Dursun et al.,29 in their study of 179 pediatric patients, observed abdominal and flank pain in 56% and macroscopic hematuria in 14% of the cases. The main anatomic alteration detected in the study group was ureteropelvic junction obstruction, and calcium oxalate was the most frequently identified chemical constituent.
Anatomic alterations were present in 18% of the cases in the present study, of which pyeloureteral duplication was the most frequent one. Ureteropelvic junction obstruction was the most common abnormality in the study by Dursun et al.29 Alpav et al.31 found that vesicoureteral reflux was the most prevalent abnormality, which would lead to urinary stasis and calculus formation.
Hypercalciuria was the most frequently found disorder and pyeloureteral duplication was the most common anatomical alteration; moreover, calcium oxalate was the most frequent chemical calculus constituent. There are no differences regarding the metabolic disorders between sexes and age ranges, but only regarding the clinical presentation. The present study was important as it analyzed the characteristics of pediatric patients with nephrolithiasis in our region.
1. Vahlensieck EW, Bach D, Hesse A. Incidence, prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res 1982; 10:161-4. [ Links ]
2. Borghi L, Ferretti PP, Elia GF et al. Epidemiological study of urinary tract stones in a Northern Italian City. Br J Urol 1990; 65:231-5. [ Links ]
3. Edvardsson V, Elidottir H, Indridason O, Palsson R. High incidence of kidney stones in Icelandic children. Pediatr Nephrol 2005; 20:940-4. [ Links ]
4. VanDervoort K, Wiesen J, Frank R et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007; 177:2300-5. [ Links ]
5. Gearhart JP, Herzberg GZ, Jeffs RD. Childhood urolithiasis: experiences and advances. Pediatrics 1991; 87:445-50. [ Links ]
6. Noe HN, Stapleton FB, Jerkins GR, Roy S. Clinical experience with pediatric urolithiasis. J Urol 1983; 129:1166-8. [ Links ]
7. Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clin Proc 1993; 68:241-8. [ Links ]
8. Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr 2009; 21:214-9. [ Links ]
9. Guven AG, Koyun M, Baysal YE et al. Urolithiasis in the first year of life. Pediatr Nephrol 2010; 25:129-34. [ Links ]
10. Stapleton FB. Childhood stones. Endocrinol Metab Clin North Am 2002; 31:1001-5. [ Links ]
11. Spivacow FR, Negri AL, del Valle EE, Calviño I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129-33. [ Links ]
12. Worcester EM, Coe FL. Nephrolithiasis. Prim Care Clin Office Pract 2008; 35:369-91. [ Links ]
13. Ozokutan BH, Kucukaydın M, Gunduz Z, Kabaklioglu M, Okur H, Turan C. Urolithiasis in childhood. Pediatr Surg Int 2000; 16:60-3. [ Links ]
14. Del Valle EE, Spivacow FR, Zanchetta JR. Metabolic evaluation at the time of the first renal lithiasis episode. Medicina 1999; 59:417-22. [ Links ]
15. Novak TE, Lakshmanan Y, Trock BJ, Gearhart JP, Matlaga BR. Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology 2009; 74:104-7. [ Links ]
16. Polito C, La Manna A, Cioce F, Villani J, Nappi B, Di Toro R. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol 2000; 15:211-14. [ Links ]
17. Basaklar AC, Kale N. Experience with childhood urolithiasis. Report of 196 cases. Br J Urol 1991; 67:203-5. [ Links ]
18. Stapleton FB, McKay CP, Noe HN. Urolithiasis in children: the role of hypercalciuria. Pediatr Ann 1987; 16: 980-1. [ Links ]
19. Lieberman E. Importance of metabolic contributions to urolithiasis in pediatric patients. Mayo Clin Proc 1993; 68:313-15. [ Links ]
20. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 8:1568-73. [ Links ]
21. Loredo-Osti JC, Roslin NM, Tessier J, Fujiwara TM, Morgan K, Bonnardeaux A. Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int 2005; 68:966-71. [ Links ]
22. Vezzoli G, Soldati L, Gambaro G. Update on primary hypercalciuria from a genetic perspective. J Urol 2008; 179:1676-82. [ Links ]
23. Reed BY, Heller HJ, Gitomer WL, Pak CY. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q233-q24. J Clin Endocrinol Metab 1999; 84:3907-13. [ Links ]
24. Reed BY, Gitomer WL, Heller HJ et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 2002; 87:1476-85. [ Links ]
25. Vezzoli G, Tanini A, Ferrucci L et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 2002; 13:2517-23. [ Links ]
26. Imamura K, Tonoki H, Wakui K et al. 4q33-qter deletion and absorptive hypercalciuria: report of two unrelated girls. Am J Med Genet 1998; 78:52-4. [ Links ]
27. Tefekli A, Esen T, Ziylan O et al. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 2003; 70:273-77. [ Links ]
28. Rizvi SA, Sultan S, Zafar MN et al. Evaluation of children with urolithiasis. Indian J Urol 2007; 23:420-7. [ Links ]
29. Dursun I, Poyrazoglu HM, Dusunsel R et al. Pediatric urolithiasis: an 8-year experience of single centre. Int Urol Nephrol 2008; 40:3-9. [ Links ]
30. Naseri M, Varasteh AR, Alamdaran SA. Metabolic factors associated with urinary calculi in children. Iran J Kidney Dis 2010; 4:32-8. [ Links ]
31. Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatric Nephrol 2009; 24:2203-9. [ Links ]
32. Spahi MA, Heidarj A, Shajari A. Clinical manifestations and etiology of renal stones in children less than 14 years age. Saudi J Kidney Dis Transpl 2010; 21:181-4. [ Links ]
Corresponding author: Submitted on: 10/31/2010 The present study was carried out at Universidade Estadual do Oeste do Paraná - UNIOESTE, Cascavel, Paraná, Brazil.
Luis Alberto Batista Peres
R. São Paulo, 769- Ap 901- Centro
Cascavel - PR - Brazil CEP: 85801-020
Approved on: 12/23/2010
The authors declare no conflict of interestinteresse.
Submitted on: 10/31/2010
The present study was carried out at Universidade Estadual do Oeste do Paraná - UNIOESTE, Cascavel, Paraná, Brazil.